2,000
Participants
Start Date
September 25, 2015
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Discontinuation of antiviral treatment in chronic hepatitis B cohort patients
For the selective patients in the cohort with long-term antiviral therapy and with conditions such as HBeAg negative or loss more than one year, antiviral therapy is able to be discontinued with an intensive inspection who agreed to the process. If there are need of this intervention, another multicenter IRB approval will be taken.
RECRUITING
Department of Internal Medicine, Yonsei University College of Medicine, Seoul
Yonsei University
OTHER